Alison Farrell
@alisonfarrell.bsky.social
Biomedical science editor & communicator, senior editor @PLOSMedicine, fascinated by mechanisms of human disease.
This is a heartbreaking read and from this editor's view, @nature.com has some soul searching to do www.science.org/content/arti...
Exclusive: Death of girl in Chinese gene-editing trial was never made public
Parents want accountability after study went disastrously wrong, Science and Retraction Watch investigation reveals
science.org
Great shout out in Science to Lise Jamieson and colleagues' new paper in @plosmedicine.org dx.plos.org/10.1371/jour... from @cohenjon.bsky.social on roadbumps in the lenacapavir roll out for #HIVPrEP
Optimising scale-up of injectable lenacapavir for HIV pre-exposure prophylaxis in South Africa: A modelling study and economic evaluation
Author summary Why was this study done? Lenacapavir has shown remarkable efficacy in preventing HIV acquisition in clinical trials and recently became available in South Africa for early implementa...
dx.plos.org
Science Magazine@science.org · 2w agoOne shot of lenacapavir, a new HIV prevention drug, can protect for 6 months—but aid cuts and uncertain demand mean little drug has reached the countries that most need it. Learn more: https://scim.ag/4hvA6m6
Responses to viral outbreaks have changed. In this Editorial, Rebecca Grais outlines how #COVID-19 transformed #outbreak responses from a predominantly public health challenge to a political & security concern, highlighting challenges of managing competing fears and risks🧪 #MedSky plos.io/4fRycuP
Whose fears count? Legitimacy, trust and viral outbreak responses after COVID-19
In this Editorial, Rebecca Grais outlines how COVID-19 transformed viral outbreak responses from a predominantly public health challenge into a political and security concern, highlighting the challen...
plos.io
Less than 2hrs left to submit comments on the OMB rule change on science funding, collaboration and communication. This is so important:https://www.regulations.gov/document/OMB-2026-0034-0001
Read this editorial by @holdenthorp.bsky.social on the proposed OMB rule changes that will stifle US science and the pharmaceutical industry. Another red alert for American science | Science www.science.org/doi/10.1126/...
Another red alert for American science
Although research has bipartisan support in the US Congress, and trust in science is above 75% across the country, the Trump administration seems as determined as ever to mortally wound the nation’s s...
science.org
For anyone applying for US federal funding, this is essential reading for changes governing grants. Stick it into an AI tool for a faster summary. www.federalregister.gov/documents/20...
Regulation for Federal Financial Assistance
The Office of Management and Budget (OMB) proposes to revise the Guidance for Federal Financial Assistance to improve government- wide policies and requirements related to the management of grants, co...
federalregister.gov
📸Some of our editors enjoying the #MSFSciDays conference in London! Please do come along to the @plos.org stand and say hello if you are attending!
PLOS@plos.org · 3mo agoWe are excited to be in London today for @msf.ca Scientific Days and look forward to meeting with communities who are shaping the future of humanitarian global health 🤝 If you are attending, come and say hello to our editors from @plosone.org and @plosmedicine.org! #MSFSciDays @msfsci.bsky.social
Great chat today with @plosmedicine.org academic editor @madhupai.bsky.social about all things @plos.org, science publishing, the state of science, and of course, the #Habs!
Madhu Pai, MD, PhD@madhupai.bsky.social · 3mo agoI've been an Academic Editor with @plosmedicine.org for many years Today, I got to meet Dr @alisonfarrell.bsky.social, a Senior Editor of PLOS Medicine, in person She is a McGill University alumna and her alma mater is proud of her many contributions to science!
Check out what's going on @plosglobalpublichealth.org
PLOS Global Public Health@plosglobalpublichealth.org · 3mo agoWe are highlighting recent studies that deepen our understanding of health systems, equity, and outcomes across a range of settings, helping to inform future research and practice. Read recent research and learn how to publish with us: plos.io/4tKHaP9
April 24-30 is #WorldImmunizationWeek. Check out some of our recent content in @plosmedicine.org highlighting the importance of #immunization and #vaccines research.
PLOS Medicine@plosmedicine.org · 3mo agoIt's #WorldImmunizationWeek 💉this year's theme is "for every generation, vaccines work". This week we are amplifying this message by highlighting research & perspectives evaluating & demonstrating the efficacy, safety, cost-effectiveness & impact of #vaccines in protecting health & saving lives🧪
Congratulations @astraight.bsky.social , newly elected to the American Academy of Arts & Sciences!! @stanfordmedicine.bsky.social www.amacad.org/new-members-...
New Academy Members
Elected in 2026
amacad.org
This is a heartbreaking read and underscores the devastating and far-reaching toll that vaccine hesitancy can take. www.nytimes.com/2026/04/21/o...
Opinion | Measles Took My Daughter. This Is What I Want Everyone to Know.
nytimes.com
Conference attendance! Associate Editor Katarzyna (Kasia) Starowicz is attending The Asian Conference on Aging & Gerontology 2026 in Tokyo, Japan. If you wish to discuss your research or the journal, do reach out and say hi! 🧪 #AGEN2026
Conference attendance! If you're heading to the European Lung Cancer Congress in Copenhagen, keep an eye out for our Senior Editor Alex Tosun! 🧪 #ELCC26 @atosun.bsky.social
atosun.bsky.social@atosun.bsky.social · 4mo agoExcited to be heading to Copenhagen for #ELCC26 @myesmo.bsky.social, on behalf of @plosmedicine.org! If you’re attending and would like to chat about your latest research or explore publishing opportunities with PLOS, let’s connect. Feel free to say hello at the conference or reach out on BlueSky.
Looking forward to attending #CROI2026 starting this Sunday in Denver and representing @plosmedicine.org ! Hope to see you there! bsky.app/profile/plos...
PLOS Medicine@plosmedicine.org · 6mo agoConference attendance! PLOS Medicine Senior Editor Alison Farrell (@alisonfarrell.bsky.social) will be attending CROI 2026 in Denver, Colorado, next week. If you want to discuss your research, the journal, Open Access publishing, or more, do reach out and say hi! #CROI2026
Now out in @plosmedicine.org, an important new Perspective on #mpox from @who.int journals.plos.org/plosmedicine...
The mpox epidemic is not over: Reducing disproportionate burden in Africa and persistent global risk require a sustained response
The 2022 mpox outbreak quickly made headlines and galvanized global attention; but the epidemic is not over. In this Perspective, Rosamund Lewis and colleagues highlight ongoing mpox outbreaks across ...
journals.plos.org
@plosmedicine.bsky.social is setting the standard for health dataset studies dx.plos.org/10.1371/jour...
Setting the standard for high-quality studies using open health datasets
Large open health datasets present unique opportunities for studies that when well-designed, conducted, and reported, can offer valuable contributions to health and medicine. However, recent years hav...
dx.plos.org
The transition from prison to community is often a socially and medically vulnerable moment for persons deprived of liberty (PDL). Our previous work found that PDL in Brazil have 3x ⬆️ risk of mortality after prison release compared with others in their community 1/5 journals.plos.org/plosmedicine...
All-cause and cause-specific mortality during and following incarceration in Brazil: A retrospective cohort study
In a retrospective cohort study, Yiran E Liu and colleagues investigate all-cause and cause-specific mortality during and following incarceration in Brazil.
journals.plos.org
In a previous article that we published in 2019, we showed evidence that: "Donor exits can create shocks to a country’s health system—affecting human resources for health, service delivery, medicines and technologies, and health financing" 3/n journals.plos.org/plosmedicine...
Middle-income countries graduating from health aid: Transforming daunting challenges into smooth transitions
Gavin Yamey and co-authors discuss approaches to providing support for middle-income countries transitioning away from health aid.
journals.plos.org
🚬 Une nouvelle étude, sur 22 cohortes et plus de 300.000 personnes, vient confirmer les risques du tabagisme et la nécessité de l'arrêt complet (et non pas la simple diminution) journals.plos.org/plosmedicine...
Association between cigarette smoking status, intensity, and cessation duration with long-term incidence of nine cardiovascular and mortality outcomes: The Cross-Cohort Collaboration (CCC)
Using data from 22 prospective cohort studies, Erfan Tasdighi and colleagues investigate the relationships among smoking burden, intensity, and cessation duration across multiple cardiovascular outcom...
journals.plos.org
In this Perspective, Petra Heitkamp, Obioma Chijioke-Akaniro & @madhupai.bsky.social discuss why abrupt international funding cuts, while threatening #tuberculosis services, also present an opportunity for a more self-reliant response led by high-burden countries🧪 journals.plos.org/plosmedicine...
From dependence to self-reliance: The future of the global tuberculosis response
In this Perspective, Madhukar Pai and colleagues highlight that while international health aid cuts are impacting the tuberculosis response, they also present an opportunity to shift towards a more eq...
journals.plos.org
In recognition of World AIDS Day 2025, this Perspective by Gregory Folkers & Anthony Fauci reflects on progress made in #antiretroviral treatments & prevention of HIV/AIDS, highlighting promising therapeutic developments and looking ahead to what is needed to end the #AIDS epidemic 🧪 plos.io/48np3Fu
Treatment and prevention of HIV/AIDS: Unfinished business
In recognition of World AIDS Day 2025, this Perspective by Gregory Folkers and Anthony Fauci reflects on the progress made in antiretroviral treatments and prevention of HIV/AIDS, highlighting promisi...
plos.io
Thrilled to see the Perspective by Dr. Tony Fauci and Dr. Greg Folkers in @plosmedicine.bsky.social on #WorldAIDSDay commemorating progress achieved against #AIDS and the critical challenge to sustain it. plos.io/48np3Fu
Treatment and prevention of HIV/AIDS: Unfinished business
In recognition of World AIDS Day 2025, this Perspective by Gregory Folkers and Anthony Fauci reflects on the progress made in antiretroviral treatments and prevention of HIV/AIDS, highlighting promisi...
plos.io
Exciting first day at #ERSCongress in Amsterdam and hearing all the updates in #respiratorymedicine. Can you see your study in #PLOSMedicine? If so, please reach out! #ERS2025 @plos.org
Check out this new Perspective by #PLOSMedicine academic editor @petermacp.bsky.social and colleagues on the devastating effects on progress of health funding cuts in Africa: journals.plos.org/plosmedicine... @plos.org
Reductions in development assistance for health funding threaten decades of progress in Africa
Countries across Africa face health crises driven by aid cuts, shifting demography, and infectious and environmental threats. Renewed public health strategies, smarter investment, and stronger surveil...
journals.plos.org
This is extraordinarily shortsighted and limits the US' ability to respond to a pandemic: www.msn.com/en-us/politi...
MSN
msn.com
PLOS Medicine has a new team and is setting priorities to help address global health challenges. Read the editorial here: dx.plos.org/10.1371/jour... @plos.org
Charting the future of PLOS Medicine: Priorities for evidence, impact, and equity
As PLOS Medicine enters a new chapter, its leadership sets out a bold editorial vision grounded in evidence, impact and equity. In a rapidly evolving global health landscape, the journal reaffirms its...
dx.plos.org
SPIRIT 2025 is now live at PLOS Medicine! doi.org/10.1371/jour... Hot on the heels of the CONSORT 2025 statement, these updates aim to improve transparency and reporting quality of clinical protocols and randomized trials, respectively. See our accompanying editorial here doi.org/10.1371/jour...
SPIRIT 2025 statement: Updated guideline for protocols of randomised trials
A complete, transparent, and accessible protocol is critical for the planning, conduct, reporting, and external review of randomised trials The SPIRIT (Standard Protocol Items: Recommendations for I...
journals.plos.org
Massive loss to #FDA, #vaccine research and safety and #science www.nytimes.com/2025/03/28/h...
Top FDA Vaccine Official Resigns, Citing Kennedy’s ‘Misinformation and Lies’
Dr. Peter Marks, a veteran of the agency, wrote that undermining confidence in vaccines is irresponsible and a danger to public health.
nytimes.com
